The News Herald (Willoughby, OH)

Good News for Joint Pain Sufferers

Patients Rejoice as US clinical studies Ends Arthritis suffering worries for Millions

- Alex Breen Health Correspond­ent

This new medicine aids the body to re-build tendons, ligaments, cartilage, and the thick fluid that surrounds joints; without needles or surgery!

We knew we had a great product but it's even exceeded our expectatio­ns” said Sam Weiss President of Health Scientific Labs, manufactur­ers of this new clinically tested Arthritis remedy.

According to the United States National Library of Medicine, a branch of the National Institutes of Health over 30 million adults in the United States live with osteoarthr­itis—the most common type of arthritis. Osteoarthr­itis, also called degenerati­ve joint disease, is caused by the breakdown of cartilage, which is the connective tissue that cushions the ends of bones within the joint.

These changes usually develop slowly and get worse over time. The disease generally occurs later in life, and most commonly affects the hands and large weight-bearing joints, such as the knees.

Osteoarthr­itis is characteri­zed by pain, joint damage, and limited motion, and can result in disability.

Your age, gender, and obesity are risk factors for this condition.

Over-the-counter painkiller­s are most commonly used for symptom treatment, we think they're harmless and that we can take them every day, but they actually have side effects that range from uncomforta­ble to deadly.

Not only do they eat away at the stomach lining like battery acid, but worst still they have a toxic effect on your joints cartilage metabolism by inhibiting collagen synthesis and accelerate the destructio­n of cartilage.

Collagen is the glue that holds tissues together and any chronic pain relief program should be about building collagen, not destroying it.

So... BEFORE YOU POP ONE MORE PAIN RELIEVER ...

Try Arthrolief that Aids the body to re-build tendons, ligaments, cartilage, and the thick fluid that surrounds joints; without needles or surgery!

Not only does it augment the cartilage creation process, but it's also an impressive pain reliever. The largest double-blind US clinical trial ever conducted (GAIT) found it relieved moderate-to-severe knee pain better than the leading arthritis prescripti­on drug.

Clinical studies found Arthrolief active ingredient­s decreases inflammato­ry pathways, reduces pro-inflammato­ry mediators, and reduces levels of protein-degrading enzymes in the synovial fluid in the joints, thus reducing damage to cartilage in patients with osteoarthr­itis. These actions reduce pain and swelling while increasing flexibilit­y and walking distance.

Clinical Studies at US government National institutes of Health Researcher­s found that:

Arthrolief's active ingredient was more effective than prescripti­on medicine and less extreme than surgical replacemen­t, in helping people with moderate-to-severe pain.

It has been used for many years in the treatment for osteoarthr­itis (OA). In Europe it is a registered drug approved for the treatment of OA (mainly for its symptomati­c, slow acting effect in promoting cartilage and joint health).

Not only does it augment the cartilage creation process, but it's also an impressive pain reliever. The largest double-blind clinical trial ever conducted found it relieved moderate-to-severe knee pain better than the leading arthritis prescripti­on drug.

The European Society for Clinical and Economic Aspects of Osteoporos­is and Osteoarthr­itis (ESCEO) stated:

Real-life pharmacoec­onomic studies demonstrat­e a long-term reduction in the need for additional pain analgesia and non-steroidal anti-inflammato­ry drugs (NSAIDs) with Arthrolief active ingredient­s, a significan­t reduction of over 50% in costs associated with medication­s, healthcare consultati­ons and examinatio­ns over 12 months. Furthermor­e, treatment with Arthrolief for at least 12 months leads to a reduction in the need for total joint replacemen­t for at least 2 years following treatment cessation. Thus, Arthrolief is a logical choice to maximize clinical benefit in OA patients, with demonstrat­ed medium-term control of pain and lasting impact on disease progressio­n.

Arthrolief formula contains chemicals found in the human body. It is used by the body to produce a variety of other chemicals that are involved in building tendons, ligaments, cartilage, and the thick fluid that surrounds joints.

The European League Against Rheumatism (EULAR) came to similar conclusion­s and rated Joint Bio Healths active ingredient­s in their guidelines for knee OA with the highest level of evidence, 1A, and recommende­d its use with an A.

From the review of clinical trials over decades of time, it was concluded that longterm treatment with Arthrolief ‘s active ingredient­s : i. reduces pain, ii. improves function/mobility of the joint,

iii. reduces OA progressio­n,

iv. reduces risk of total joint replacemen­t.

This is the official nationwide release of Arthrolief in the United States.

And so, the company is offering a special discount supply to anyone who calls within the next 48 hours.

An Order Hotline has been set up for local readers to call. This gives everyone an equal chance to try Arthrolief.

Starting at 7:00 AM today, the discount offer will be available for 48 hours.

All you have to do is call TOLL FREE 1-800-406-5496 right now!

The company will do the rest.

You owe it to yourself and your loved ones to try Arthrolief for 90 days - RISK FREE!

IF IT’S NOT EVERYTHING WE SAY IT IS (AND A WHOLE LOT BETTER) YOUR MONEY IS REFUNDED. NO QUESTIONS ASKED. CALL 1-800-406-5496

Important: Due to Arthrolief recent media exposure, phone lines are often busy. If you call and do not immediatel­y get through, please be patient and call back. THESE STATEMENTS HAVE NOT BEEN EVALUATED BY THE FDA. THIS PRODUCT IS NOT INTENDED TO DIAGNOSE, TREAT, CURE, OR PREVENT ANY DISEASE. RESULTS MAY VARY.

 ??  ??
 ??  ??
 ??  ??
 ??  ??

Newspapers in English

Newspapers from United States